Cutler Group LP Genetic Technologies LTD Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Jul 19, 2021	SELL	$0.0 - $0.02 $0 - $16	-800 Reduced 44.44%	1,000 $0
Q1 2021 Apr 26, 2021	SELL	$0.0 - $0.01 $0 - $120	-12,000 Reduced 86.96%	1,800 $0
Q4 2020 Jan 21, 2021	BUY	$0.0 - $0.0 $0 - $0	13,700 Added 13700.0%	13,800 $4,000
Q3 2020 Oct 27, 2020	BUY	$0.0 - $0.0 $0 - $0	100 New	100 $0

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.